Clinical Trial Update: COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement [Phase 2, Phase 3]

View source ↗

Summary

A knee replacement pain management trial titled COPE evaluating cannabinoids in Phase 2 and Phase 3; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroplasty Replacement Knee

Drugs mentioned

• Cannabinoids to Obviate Pain Experiment After Knee Replacement (cannabinoids)

Snippet

Sponsor: Unity Health Toronto | Conditions: Arthroplasty, Replacement, Knee | Phase 2, Phase 3 | Status: UNKNOWN